Acticor Biotech Collecte 590 K€ Pour Son Entrée En Pré-Clinique By Hélène Leclerc – Published on January 30, 2015 | Bf No.667 Dédiée depuis fin 2013 au développement d’un traitement d’urgence des accidents vasculaires cérébraux (AVC) ischémiques, Acticor Biotech, a pour sa part fédéré 590 k€ en amorçage. Deux tiers des capitaux ont été obtenus […]
Media Coverage
February 2, 2015
Biotech Finances : Acticor Biotech collects 590k€ to start its preclinical development
February 1, 2015
LABIOTECH.fr: Acticor Biotech wins its crowdfunding bet!
Acticor Biotech réussi le pari du crowdfunding! By Joachim – Published on January 29, 2015 | LABIOTECH.fr Read in English : Biotech’s crowdfunding: is France top of the class? In France, you can feel a real enthousiasme for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand […]
January 2, 2015
LABIOTECH.eu: Biotech’s crowdfunding: is France top of the class?
Biotech’s crowdfunding: is France top of the class? By Joachim Eeckhout – Published on December 22, 2014 | LABIOTECH.eu In France, you can feel a real enthusiasm for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, […]
November 30, 2014
BioPharmAnalyses.fr: Acticor Biotech selects its first lead compound
Acticor Biotech sélectionne son premier lead By Anne Lise Berthier – Published on November 03, 2014 | No.81 Classé parmi les urgences médicales absolues, l’accident vasculaire cérébral (AVC) touche chaque année 155 000 nouvelles personnes en France et reste une des principales causes de mortalité et la première cause de handicap acquis de l’adulte. Bien […]
November 26, 2014
Gilles Avenard guest of “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference
Gilles Avenard, Acticor Biotech CEO is invited to talk about the relationships between Business Angels and startups in the field of human health. The “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference is organized by Angels Santé, the leading Business Angels network in France, and the Public Bank for Investment (BPI), […]
November 25, 2014
Acticor Biotech featured in Usine Nouvelle magazine (n°3396)
Acticor Biotech cible les AVC by Thérèse Bouveret – published on November 1st, 2014, at 04:55pm | L’Usine Nouvelle n° 3396 Read the article in French on l’Usine Nouvelle website.